ACCESSION: MSBNK-SMB_Measured-HSA033P0184000
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.03.25 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.03.25, Curated 2025.03.25)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 89
COMMENT: RAW_SPEC {'D64neg_4041': {'bp': 4420.0, 'sum': 5959.0}, 'D66neg_3995': {'bp': 4418.0, 'sum': 6378.0}, 'C16neg_3958': {'bp': 4057.0, 'sum': 6032.0}, 'D102neg_3889': {'bp': 3800.0, 'sum': 5633.0}, 'D66neg_4049': {'bp': 3519.0, 'sum': 5378.0}, 'C1neg_3850': {'bp': 3479.0, 'sum': 4697.0}, 'D102neg_3899': {'bp': 3436.0, 'sum': 4535.0}, 'D64neg_3992': {'bp': 3114.0, 'sum': 4317.0}, 'C1neg_3858': {'bp': 3034.0, 'sum': 4783.0}, 'D65neg_3965': {'bp': 2983.0, 'sum': 4349.0}, 'C14neg_3792': {'bp': 2942.0, 'sum': 3697.0}, 'D126neg_4044': {'bp': 2933.0, 'sum': 4215.0}, 'D168neg_3973': {'bp': 2907.0, 'sum': 4408.0}, 'D126neg_3996': {'bp': 2711.0, 'sum': 3650.0}, 'C11neg_3853': {'bp': 2629.0, 'sum': 3703.0}, 'D143neg_3909': {'bp': 2488.0, 'sum': 3453.0}, 'D87neg_3984': {'bp': 2419.0, 'sum': 3447.0}, 'C12neg_3846': {'bp': 2377.0, 'sum': 3642.0}, 'C11neg_3858': {'bp': 2360.0, 'sum': 3506.0}, 'D99neg_3975': {'bp': 2329.0, 'sum': 3573.0}, 'D178neg_3871': {'bp': 2301.0, 'sum': 3302.0}, 'C13neg_3943': {'bp': 2266.0, 'sum': 3702.0}, 'C9neg_3947': {'bp': 2126.0, 'sum': 2927.0}, 'D207neg_4010': {'bp': 2088.0, 'sum': 2870.0}, 'C4neg_3852': {'bp': 2080.0, 'sum': 2952.0}, 'D87neg_4025': {'bp': 2079.0, 'sum': 3204.0}, 'C4neg_3860': {'bp': 2059.0, 'sum': 2911.0}, 'C7neg_3966': {'bp': 1990.0, 'sum': 2992.0}, 'C9neg_3994': {'bp': 1980.0, 'sum': 2882.0}, 'C18neg_3893': {'bp': 1937.0, 'sum': 2525.0}, 'C15neg_3791': {'bp': 1868.0, 'sum': 2743.0}, 'D171neg_3945': {'bp': 1789.0, 'sum': 2701.0}, 'D171neg_3932': {'bp': 1788.0, 'sum': 2581.0}, 'D121neg_3910': {'bp': 1659.0, 'sum': 2591.0}, 'D73neg_3989': {'bp': 1649.0, 'sum': 2665.0}, 'D170neg_3867': {'bp': 1621.0, 'sum': 2383.0}, 'C18neg_3887': {'bp': 1558.0, 'sum': 2099.0}, 'D119neg_3897': {'bp': 1525.0, 'sum': 2128.0}, 'D122neg_4101': {'bp': 1507.0, 'sum': 2574.0}, 'D121neg_3868': {'bp': 1480.0, 'sum': 2157.0}, 'D66neg_3981': {'bp': 1461.0, 'sum': 2193.0}, 'D73neg_4025': {'bp': 1438.0, 'sum': 2150.0}, 'D65neg_3922': {'bp': 1426.0, 'sum': 2023.0}, 'D74neg_3878': {'bp': 1425.0, 'sum': 1803.0}, 'D145neg_3912': {'bp': 1419.0, 'sum': 1839.0}, 'D69neg_3813': {'bp': 1410.0, 'sum': 2052.0}, 'D147neg_4129': {'bp': 1405.0, 'sum': 2648.0}, 'D108neg_3980': {'bp': 1347.0, 'sum': 1725.0}, 'D122neg_4090': {'bp': 1340.0, 'sum': 1932.0}, 'D147neg_4082': {'bp': 1333.0, 'sum': 1795.0}, 'C3neg_3991': {'bp': 1320.0, 'sum': 1847.0}, 'C12neg_3836': {'bp': 1306.0, 'sum': 2319.0}, 'D145neg_3947': {'bp': 1196.0, 'sum': 1935.0}, 'C18neg_3940': {'bp': 1188.0, 'sum': 1631.0}, 'D136neg_3810': {'bp': 1186.0, 'sum': 1691.0}, 'C17neg_3846': {'bp': 1124.0, 'sum': 1521.0}, 'D207neg_4061': {'bp': 1087.0, 'sum': 1807.0}, 'D94neg_3954': {'bp': 1064.0, 'sum': 1599.0}, 'D108neg_4031': {'bp': 1018.0, 'sum': 1517.0}, 'C17neg_3840': {'bp': 1008.0, 'sum': 1402.0}, 'C9neg_3939': {'bp': 989.0, 'sum': 1624.0}, 'C2neg_4004': {'bp': 984.0, 'sum': 1546.0}, 'C13neg_3896': {'bp': 934.0, 'sum': 1357.0}, 'D74neg_3870': {'bp': 914.0, 'sum': 1307.0}, 'D73neg_3977': {'bp': 832.0, 'sum': 1210.0}, 'D119neg_3887': {'bp': 814.0, 'sum': 1276.0}, 'C15neg_3776': {'bp': 811.0, 'sum': 1189.0}, 'D170neg_3860': {'bp': 809.0, 'sum': 1203.0}, 'D108neg_4023': {'bp': 782.0, 'sum': 1383.0}, 'D117neg_4073': {'bp': 777.0, 'sum': 1113.0}, 'C13neg_3889': {'bp': 758.0, 'sum': 1123.0}, 'D99neg_3966': {'bp': 718.0, 'sum': 1012.0}, 'C6neg_4002': {'bp': 700.0, 'sum': 1191.0}, 'D69neg_3808': {'bp': 696.0, 'sum': 1090.0}, 'C14neg_3849': {'bp': 691.0, 'sum': 1023.0}, 'D94neg_3920': {'bp': 658.0, 'sum': 1117.0}, 'D145neg_3900': {'bp': 643.0, 'sum': 853.0}, 'C6neg_3959': {'bp': 629.0, 'sum': 1076.0}, 'C16neg_3900': {'bp': 580.0, 'sum': 790.0}, 'D203neg_3809': {'bp': 578.0, 'sum': 767.0}, 'D121neg_3856': {'bp': 563.0, 'sum': 1025.0}, 'D84neg_3929': {'bp': 553.0, 'sum': 842.0}, 'D83neg_4125': {'bp': 534.0, 'sum': 1332.0}, 'D147neg_4070': {'bp': 497.0, 'sum': 1001.0}, 'D203neg_3841': {'bp': 403.0, 'sum': 613.0}, 'D146neg_3847': {'bp': 330.0, 'sum': 467.0}, 'C5neg_3931': {'bp': 322.0, 'sum': 364.0}, 'D146neg_3836': {'bp': 210.0, 'sum': 294.0}, 'D169neg_3858': {'bp': 204.0, 'sum': 289.0}}
COMMENT: RETENTION_TIME_STDEV 0.031
COMMENT: PRECURSOR_M/Z_RAW 184.072442
COMMENT: PRECURSOR_M/Z_STDEV 0.000673
COMMENT: PRECURSOR_IN_MS1 mz 184.072600; int 73.288; delta(ppm) -0.366215
COMMENT: PROPOSED_CHARGE_STATE -1; mz 185.075934; int 5.636; cor 0.958
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M+Na-2H; mz 206.054425; int 1.913; cor 0.893
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 17.247; C6H12N5P; [M-H]1; delta(ppm) -17.246611
COMMENT: PROPOSED_MF SevenGoldenRules 1.097; C7H11N3O3; [M-H]1; delta(ppm) -1.096824
COMMENT: PROPOSED_MF MS-FINDER 4.386; C7H11N3O3; [M-H]-; delta(ppm) -1.101777
COMMENT: PROPOSED_MF MS-FINDER 3.031; C5H16NO4P; [M-H]-; delta(ppm) -10.075131
COMMENT: PROPOSED_MF MS-FINDER 2.760; C4H15N3O3S; [M-H]-; delta(ppm) -19.415525
COMMENT: PROPOSED_MF SIRIUS5_Sirius 16.775; C7H11N3O3; [M-H]-; delta(ppm) -1.101777
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H11N3O3; [M-H]-; delta(ppm) -1.101777
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.288; C7H11N3O3; [M-H]-; delta(ppm) -1.101777
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.294; C4H12FN3O4; [M-H]-; delta(ppm) -7.309353
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.834; C5H9N6O2; [M-H]-; delta(ppm) 6.192468
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.742; C3H14N4O3P; [M-H]-; delta(ppm) -2.781017
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.729; C2H12ClN7O; [M-H]-; delta(ppm) -115341.603141
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.633; CH12N7O2P; [M-H]-; delta(ppm) 4.513204
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.604; C9H13O4; [M-H]-; delta(ppm) -8.395916
COMMENT: PROPOSED_MF SIRIUS6_Sirius -5.539; H11N9OS; [M-H]-; delta(ppm) -4.827462
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H11N3O3; [M-H]-; delta(ppm) -1.101777
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.787; BDIXWZLLNILION-UHFFFAOYSA-N; [M-H]-; O=C1NC=C(NCCCO)C(=O)N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.667; XFNJVKMNNVCYEK-UHFFFAOYSA-N; [M-H]-; NC(=O)CC1=CC=CC2=C1C=CC=C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.450; LBQFDLRXNAORNL-UHFFFAOYSA-N; [M-H]-; O=C(N)CN1C(=O)CCC1C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.191; SKIVBBIKOOPRPR-UHFFFAOYNA-N; [M-H]-; CC(NC1=NC(=O)CN1C)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; NSVDPFZTGJHYDM-DSXPNFDZSA-N; [M-H]-; C/C=C/C=C/1\C=CC2=C1C(=O)C=CN2
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.371; SKIVBBIKOOPRPR-UHFFFAOYNA-N; [M-H]-; (S)-N-(4,5-Dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)alanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.983; KPQZUUQMTUIKBP-UHFFFAOYNA-N; [M-H]-; 1-(2-methyl-5-nitro-1-imidazolyl)-2-propanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.855; LBQFDLRXNAORNL-UHFFFAOYSA-N; [M-H]-; 1-(carbamoylmethyl)-5-oxopyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.806; BDIXWZLLNILION-UHFFFAOYSA-N; [M-H]-; 5-[(3-hydroxypropyl)amino]-1,2,3,4-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.766; MECFJRKHUMMFGS-HNBBVXEKNA-N; [M-H]-; UNPD197249
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.303; DUOHVNSMLSPTMI-UHFFFAOYSA-N; [M-H]-; Ternidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.251; LRAQTHRXQNHAAH-UHFFFAOYNA-N; [M-H]-; Ipronidazole-hydroxy
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SKIVBBIKOOPRPR-UHFFFAOYNA-N; [M-H]-; (S)-N-(4,5-Dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)alanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.724; LBQFDLRXNAORNL-UHFFFAOYSA-N; [M-H]-; 1-(carbamoylmethyl)-5-oxopyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.508; BDIXWZLLNILION-UHFFFAOYSA-N; [M-H]-; 5-[(3-hydroxypropyl)amino]-1,2,3,4-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.481; KPQZUUQMTUIKBP-UHFFFAOYNA-N; [M-H]-; 1-(2-methyl-5-nitro-1-imidazolyl)-2-propanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.411; DUOHVNSMLSPTMI-UHFFFAOYSA-N; [M-H]-; Ternidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.411; LRAQTHRXQNHAAH-UHFFFAOYNA-N; [M-H]-; Ipronidazole-hydroxy
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.210; MECFJRKHUMMFGS-HNBBVXEKNA-N; [M-H]-; UNPD197249
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.481; KPQZUUQMTUIKBP-UHFFFAOYSA-N; [M-H]-; 1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.169; SKIVBBIKOOPRPR-UHFFFAOYSA-N; [M-H]-; 2-[(1-methyl-4-oxoimidazolidin-2-ylidene)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.157; FXIFXKWJMGBHHO-YFKPBYRVSA-N; [M-H]-; (2S)-2-amino-3-(2-methyl-3-oxo-1H-pyrazol-4-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.156; BIZCLBYCUPABAD-WEVVVXLNSA-N; [M-H]-; 2-[(2E)-2-carbamoyliminopyrrolidin-1-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.153; PWFDXPAAUFJSSA-UHFFFAOYSA-N; [M-H]-; 2-(4-ethyl-3-methyl-5-oxo-1,2,4-triazol-1-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.956; NOQCJLXBVDNVFG-UHFFFAOYSA-N; [M-H]-; 2-(5,5-dimethyl-2,4-dioxoimidazolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.952; LLGHIXICGJDRMU-RXMQYKEDSA-N; [M-H]-; methyl (2R)-2-amino-3-(3-oxo-1,2-dihydropyrazol-4-yl)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.879; YZEWEIJSLLACIN-UHFFFAOYSA-N; [M-H]-; 6-amino-1-(2-methoxyethyl)pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.872; MXGRRFUCRGENRR-UHFFFAOYSA-N; [M-H]-; methyl 2-[4-(1-hydroxyethyl)triazol-1-yl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.872; CVWNVAUOPWCYSN-UHFFFAOYSA-N; [M-H]-; methyl 2-[4-(2-hydroxyethyl)triazol-1-yl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.822; FATLUVZBHLRIQC-UHFFFAOYSA-N; [M-H]-; N'-(2-hydroxyethyl)-5-methyl-1,2-oxazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.816; XCAPETXPNIXJQN-UHFFFAOYSA-N; [M-H]-; 3-[3-(dimethylamino)-1,2,4-oxadiazol-5-yl]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.816; CXOIHWNPMZMTAO-UHFFFAOYSA-N; [M-H]-; ethyl 2-[3-(aminomethyl)-1,2,4-oxadiazol-5-yl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.808; DUOHVNSMLSPTMI-UHFFFAOYSA-N; [M-H]-; 3-(2-methyl-5-nitroimidazol-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.751; DTHPMNDYKOSVFR-UHFFFAOYSA-N; [M-H]-; 2-(1-methyl-5-nitroimidazol-2-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; ODSRAEZVAFOUOH-UHFFFAOYSA-N; [M-H]-; ethyl 5-(hydroxymethyl)-2-methyl-1,2,4-triazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.671; HVFBJWHGPCLJTR-UHFFFAOYSA-N; [M-H]-; ethyl 5-(hydroxymethyl)-1-methyl-1,2,4-triazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.667; UOCITRKYCKNSJL-UHFFFAOYSA-N; [M-H]-; ethyl 5-(methoxymethyl)-1H-1,2,4-triazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.667; PEHOOILBFVEUEV-SCSAIBSYSA-N; [M-H]-; ethyl 5-[(1R)-1-hydroxyethyl]-1H-1,2,4-triazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.629; OGKCPJNRQBTBPF-UHFFFAOYSA-N; [M-H]-; 2,4,6-trimethoxypyrimidin-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.620; ABGJIKXMJUSARA-UHFFFAOYSA-N; [M-H]-; 2-(5-ethyl-2-nitroimidazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.599; HRSGYKLMWRWVCM-UHFFFAOYSA-N; [M-H]-; 1-methyl-4-nitro-3-propan-2-yloxypyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.559; WLOXDXOPKNBBFP-UHFFFAOYSA-N; [M-H]-; 2-(3-methyl-2-nitroimidazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.544; WKWQIMRIQQDCEM-UHFFFAOYSA-N; [M-H]-; 1-(3-methyl-2-nitroimidazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.513; REWQNYFPXZTNHQ-UHFFFAOYSA-N; [M-H]-; tert-butyl N-(1,2,4-oxadiazol-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.544; PWADXPITHGKDSY; [M-H]-; Cyclo(-Gly-Gln)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -177.236; LBQFDLRXNAORNL; [M-H]-; 1-(2-amino-2-oxoethyl)-5-oxoprolinamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.558; SKIVBBIKOOPRPR; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.003; BDIXWZLLNILION; [M-H]-; 5-[(3-hydroxypropyl)amino]pyrimidine-2,4(1H,3H)-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.778; DUOHVNSMLSPTMI; [M-H]-; Ternidazol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.368; LRAQTHRXQNHAAH; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.990; JRXLILGOSVVPCW; [M-H]-; 1-(2-methyl-4-nitroimidazol-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -346.831; KPQZUUQMTUIKBP; [M-H]-; Flagentyl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -352.968; ABGJIKXMJUSARA; [M-H]-; 5-Ethyl-2-nitroimidazole-1-ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -374.557; HRSGYKLMWRWVCM; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -390.338; DTHPMNDYKOSVFR; [M-H]-; Ipronidazole-OH
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -420.362; FATLUVZBHLRIQC; [M-H]-; N''-(2-Hydroxyethyl)-5-methyl-3-isoxazolecarbohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -420.945; KSSIVZJLHJBIHN; [M-H]-; N-Diazoacetyl-D,L-alanine ethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -421.664; WKWQIMRIQQDCEM; [M-H]-; alpha,1-Dimethyl-2-nitroimidazole-5-ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -421.695; MECFJRKHUMMFGS; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -440.655; WLOXDXOPKNBBFP; [M-H]-; Imidazole-5-methanol,.alpha.,1-trimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.177; PWADXPITHGKDSY; [M-H]-; Cyclo(-Gly-Gln)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -185.091; NOQCJLXBVDNVFG; [M-H]-; 2-(5,5-Dimethyl-2,4-dioxoimidazolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -185.210; BWZRMBUNAOJHOY; [M-H]-; {(2S)-2-[(1S)-1-Aminoethyl]-5-oxo-2,5-dihydro-1H-imidazol-1-YL}acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.604; DUOHVNSMLSPTMI; [M-H]-; 1,1,2,2,3,3-Hexadeuterio-3-(2-methyl-5-nitroimidazol-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -228.503; SKIVBBIKOOPRPR; [M-H]-; 2-[(4-hydroxy-1-methyl-2,5-dihydro-1H-imidazol-2-ylidene)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -234.183; JJYCGTAEWKCZIP; [M-H]-; 5-[(2-hydroxyethyl)amino]-6-methylpyrimidine-2,4(1H,3H)-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -247.088; JRXLILGOSVVPCW; [M-H]-; alpha,2-Dimethyl-4-nitro-1H-imidazole-1-ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -247.088; KPQZUUQMTUIKBP; [M-H]-; Secnidazole-d6
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -247.735; ABGJIKXMJUSARA; [M-H]-; Imidazole-1-ethanol, 5-ethyl-2-nitro-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -257.784; PWADXPITHGKDSY; [M-H]-; (S)-3-(3,6-Dioxopiperazin-2-yl)propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -270.645; CVWNVAUOPWCYSN; [M-H]-; methyl 2-[4-(2-hydroxyethyl)-1H-1,2,3-triazol-1-yl]acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.123; NOQCJLXBVDNVFG; [M-H]-; 2-(5,5-Dimethyl-2,4-dioxoimidazolidin-1-yl)acetamide
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H10N3O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 Âµm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 4.297
MS$FOCUSED_ION: PRECURSOR_M/Z 184.072562
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-9000000000-c695d2ab891b4d88ade0
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  41.9981342 999.0000 41.998130 5.9050 0.00 0.8499 71 f{C1N1O1}/-9.60ppm,p-C6H10N2O2
  58.0291296 94.9720 58.029110 9.9777 45.30 0.7326 63 f{C2H4N1O1}/-12.20ppm,p-C5H6N2O2
  74.0241394 234.6828 74.024090 8.1595 87.70 1.0000 86 f{C2H4N1O2}/-8.28ppm,p-C5H6N2O1
  113.0713679 94.0087 113.071325 8.4371 36.70 0.6859 76 f{C5H9N2O1}/-5.91ppm,p-C2H1N1O2
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  41.998134 999.00 999
  58.029130 94.97 94
  74.024139 234.68 234
  113.071368 94.01 94
//
